Yingying Tong
Beijing, 101149, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
UBE2C-PI3K/AKT-mediated upregulation of MTHFD2 promotes tumor progression in hepatocellular carcinoma.
Journal: International immunopharmacology
Published: September 24, 2025
Hyperglycemia drives lmmune evasion in colorectal cancer through VISTA stabilization.
Journal: Cell communication and signaling : CCS
Published: July 26, 2025
A dsRNA Viral Transcriptional Regulator Evades Innate Immunity by Hijacking Host CoTranscription Factor DHX9.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 02, 2025
The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma.
Journal: Cell death & disease
Published: February 28, 2025
Identification of Metabolic Characteristic-Pancreatic Ductal Adenocarcinoma Associations Using Mendelian Randomization and Metabolomics.
Journal: Journal of gastrointestinal cancer
Published: January 11, 2025
A machine learning-based prognostic stratification of locoregional interventional therapies for patients with colorectal cancer liver metastases: a real-world study.
Journal: Therapeutic advances in medical oncology
Published: September 28, 2024
Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival.
Journal: International journal of colorectal disease
Published: July 09, 2024
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.
Journal: Immunity
Published: June 20, 2024
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.
Journal: Molecular cell
Published: May 23, 2024
Integrative Analysis of PAIP2B to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma.
Journal: Global medical genetics
Published: December 20, 2023
Last Updated: 09/26/2026